|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/335 | |
| A61K 31/365 | |||
| A61K 31/427 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61K 39/395 |
| (11) | Patento numeris | 1383490 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 02717548.8 |
| Europos patento paraiškos padavimo data | 2002-03-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-01-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-04-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2002/006746 |
| Data | 2002-03-05 |
| (87) | Numeris | WO 2002/072085 |
| Data | 2002-09-19 |
| (30) | Numeris | Data | Šalis |
| 275801 P | 2001-03-14 | US | |
| 316395 P | 2001-08-31 | US |
| (72) |
LEE, Francis, Y., F., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road P.O. Box 4000, Princeton NJ 08543-4000,
US
|
| (54) | COMBINATION OF AN EPOTHILONE ANALOG AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES |
| COMBINATION OF AN EPOTHILONE ANALOG AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES |